Citigroup’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-39,222
| Closed | -$446K | – | 5036 |
|
|
2023
Q4 | $446K | Buy |
+39,222
| New | +$446K | ﹤0.01% | 2766 |
|
|
2023
Q1 | – | Sell |
-4
| Closed | -$28 | – | 5095 |
|
|
2022
Q4 | $28 | Sell |
4
-39
| -91% | -$273 | ﹤0.01% | 4878 |
|
|
2022
Q3 | $0 | Sell |
43
-29
| -40% | – | ﹤0.01% | 5635 |
|
|
2022
Q2 | $1K | Sell |
72
-66
| -48% | -$917 | ﹤0.01% | 5328 |
|
|
2022
Q1 | $7K | Sell |
138
-437
| -76% | -$22.2K | ﹤0.01% | 4916 |
|
|
2021
Q4 | $43K | Buy |
575
+193
| +51% | +$14.4K | ﹤0.01% | 4376 |
|
|
2021
Q3 | $30K | Sell |
382
-10,085
| -96% | -$792K | ﹤0.01% | 4289 |
|
|
2021
Q2 | $1.45M | Buy |
10,467
+9,166
| +705% | +$1.27M | ﹤0.01% | 2347 |
|
|
2021
Q1 | $272K | Buy |
1,301
+102
| +9% | +$21.3K | ﹤0.01% | 3185 |
|
|
2020
Q4 | $199K | Buy |
1,199
+288
| +32% | +$47.8K | ﹤0.01% | 3238 |
|
|
2020
Q3 | $155K | Buy |
911
+600
| +193% | +$102K | ﹤0.01% | 2908 |
|
|
2020
Q2 | $52K | Sell |
311
-72
| -19% | -$12K | ﹤0.01% | 3761 |
|
|
2020
Q1 | $44K | Buy |
383
+36
| +10% | +$4.14K | ﹤0.01% | 3883 |
|
|
2019
Q4 | $51K | Buy |
347
+167
| +93% | +$24.5K | ﹤0.01% | 3954 |
|
|
2019
Q3 | $25K | Buy |
180
+23
| +15% | +$3.19K | ﹤0.01% | 4152 |
|
|
2019
Q2 | $20K | Buy |
157
+89
| +131% | +$11.3K | ﹤0.01% | 4585 |
|
|
2019
Q1 | $6K | Buy |
+68
| New | +$6K | ﹤0.01% | 4867 |
|